Get the Stockscreener App
22.69
1.52%
0.34
After Hours:
22.68
-0.01
-0.04%
Overview
News
Price History
Option Chain
Why FMS Down?
Discussions
Forecast
Stock Split
Dividend History
Fresenius Medical Care Ag Adr stock is traded at $22.69, with a volume of 532.83K.
It is up +1.52% in the last 24 hours and down -3.49% over the past month.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
See More
Previous Close:
$22.35
Open:
$22.45
24h Volume:
532.83K
Relative Volume:
0.77
Market Cap:
$12.08B
Revenue:
$22.44B
Net Income/Loss:
$1.35B
P/E Ratio:
11.94
EPS:
1.9002
Net Cash Flow:
$2.03B
1W Performance:
+2.21%
1M Performance:
-3.49%
6M Performance:
+1.93%
1Y Performance:
-9.96%
1-Day Range:
$22.36
$22.71
1-Week Range:
$22.19
$22.71
52-Week Range:
$20.02
$27.64
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Name
Fresenius Medical Care Ag Adr
Sector
Industry
Phone
-
Address
-
Compare FMS vs HCA, THC, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
22.69 | 12.08B | 22.44B | 1.35B | 2.03B | 1.9002 |
HCA
Hca Healthcare Inc
|
435.61 | 94.31B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
259.71 | 20.91B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
123.47 | 12.18B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
178.47 | 11.39B | 13.84B | 1.10B | 1.49B | 10.42 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Downgrade | Goldman | Buy → Neutral |
| Oct-15-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-02-25 | Downgrade | UBS | Neutral → Sell |
| Dec-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-06-24 | Initiated | Berenberg | Buy |
| Jan-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-24-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-17-23 | Upgrade | Societe Generale | Hold → Buy |
| Aug-14-23 | Downgrade | UBS | Buy → Neutral |
| Aug-01-23 | Resumed | Citigroup | Neutral |
| Jul-12-23 | Initiated | Goldman | Buy |
| Mar-07-23 | Initiated | Bernstein | Mkt Perform |
| Jan-03-23 | Downgrade | Jefferies | Buy → Underperform |
| Oct-26-22 | Downgrade | Deutsche Bank | Hold → Sell |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-27-22 | Upgrade | Jefferies | Underperform → Buy |
| Feb-11-22 | Downgrade | Jefferies | Hold → Underperform |
| Nov-23-21 | Initiated | HSBC Securities | Hold |
| Nov-11-21 | Upgrade | Jefferies | Underperform → Hold |
| Feb-04-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-03-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
| May-20-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-21-20 | Upgrade | Jefferies | Hold → Buy |
| Jun-20-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-26-18 | Upgrade | UBS | Neutral → Buy |
| Aug-28-18 | Upgrade | HSBC Securities | Hold → Buy |
| Jul-05-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Jan-04-18 | Upgrade | UBS | Sell → Neutral |
| Dec-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-06-16 | Upgrade | Citigroup | Neutral → Buy |
| Jul-08-16 | Upgrade | Jefferies | Underperform → Hold |
| Jan-04-16 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-04-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-03-15 | Upgrade | Goldman | Neutral → Buy |
| Aug-13-15 | Downgrade | Societe Generale | Buy → Hold |
| Jul-31-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-02-13 | Reiterated | Feltl & Co. | Hold |
| Jan-14-13 | Upgrade | HSBC Securities | Neutral → Overweight |
View All
Fresenius Medical Care Ag Adr Stock (FMS) Latest News
Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership - Fresenius Medical Care
The Best Healthcare Stocks to Buy - Morningstar
Statement Regarding Cybersecurity Incident - Fresenius Medical Care
Fresenius Medical Care stock falls after 2.9 percent Xetra drop - ad-hoc-news.de
Fresenius Medical Care stock gains as J.P. Morgan sticks to Sell rating and consensus targets diverg - AD HOC NEWS
Fresenius Medical Care stock stabilizes as JPMorgan stays cautious on medtech outlook - AD HOC NEWS
Fresenius Medical Care AGADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Clover Health Investments Corp. Class A (CLOV) Peer Comparison – Compare with Others - Value Research
Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis - Fresenius Medical Care
ETF Comparator - MacroMicro
Fresenius stock trades on solid footing as investors look beyond Fresenius Medical Care data - AD HOC NEWS
Fresenius Medical Care stock holds steady as mid-2026 trading data align with recent NYSE levels. - ad-hoc-news.de
Fresenius Medical Care stock trades close to analyst fair value as investors weigh guidance and sect - Ad-hoc-news.de
FMS Posts Modest Gain: Fresenius Medical Care ADRs Hold Firm Above Key SupportTrade Entry Signals - vinanet.vn
Fresenius Medical Care (FMS) Edges Higher to $23.77, Holds Range Between Key Support and ResistanceAndrews Pitchfork - vinanet.vn
Fresenius Medical Care stock steadies around $23 as investors weigh recent buybacks and guidance - ad-hoc-news.de
Fresenius Medical Care stock holds steady near $24 as investors digest latest capital market update - ad-hoc-news.de
Fresenius Medical Care stock holds near $23 as investors weigh latest earnings - ad-hoc-news.de
Fresenius Medical Care AG (FMS) Stock Forecasts - Yahoo! Finance Canada
Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript - The Globe and Mail
Weekly Recap: Q2 results & guidance reaffirmed and Cassie McLean named CEO - TradingView
Fresenius Medical Care (FMS) Advances to $24.10: Near-Term Support and Resistance in FocusEarnings Breakout Stocks - dars.gov.et
Fresenius Medical Care Q2 2026 slides: margins soar despite volume pressure - Investing.com
Fresenius Medical Care plunges 9.6% as weak U.S. volumes overshadow Q2 beat - Investing.com
Earnings call transcript: Fresenius Medical Care beats Q2 2026 EPS, shares fall - Investing.com
Why is Fresenius Medical Care stock sliding today? - Investing.com
Fresenius Medical Care ADR earnings beat by $0.31, revenue was in line with estimates - Investing.com
Fresenius Medical Care's Margin Improvement Story Looks Merely Stalled, Not Over - Morningstar
Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery - Barchart.com
Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients - Fresenius Medical Care
Why is Fresenius Medical Care stock down today? - Investing.com
BNP Paribas Exane downgrades Fresenius Medical Care stock rating on dialysis volume concerns - Investing.com
Fresenius Medical Care launches analytics tool for kidney therapy By Investing.com - Investing.com South Africa
Fresenius Medical Care launches analytics tool for kidney therapy - Investing.com
Urology Devices Market Size to Reach USD 80.0 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy - Fresenius Medical Care
FMC stock steadies as Fresenius Medical Care keeps its U.S. listing - Ad-hoc-news.de
How home hemodialysis is redefining kidney care - Fresenius Medical Care
The 5008 CorDiax from Fresenius Medical Caredialyzers built for US clinics - ad-hoc-news.de
FMC Fresenius Medical Care, background on dialysis business and stock - Ad-hoc-news.de
ETFs Investing in Fresenius Medical Care AG Sponsored ADR Stocks - TradingView
FMEA Forecast — Price Target — Prediction for 2027 - TradingView
Fresenius Medical Care with a clear strategy focus, shares on NYSE and Xetra watch - ad-hoc-news.de
879529 Forecast — Price Target — Prediction for 2027 - TradingView
Fresenius Medical Care dips after US proposes lower dialysis reimbursement rate - Investing.com
Fresenius Medical Care with clear analyst view, shares tracked on Xetra and NYSE - AD HOC NEWS
Finding strength in change: George’s journey with dialysis - Fresenius Medical Care
Fresenius Medical Care Stock (DE0005785802): Shares trade near EUR 40.90 after a modest Xetra gain - AD HOC NEWS
Fresenius Medical Care Stock (DE0005785802): Quarterly earnings keep NYSE-listed shares in focus - AD HOC NEWS
Why Is Fresenius Medical Care Stock Trending Right Now - Kalkine Media
Fresenius Medical Care Stock (DE0005785802): Technical breakout to new 4-week high - AD HOC NEWS
Fresenius Medical Care Ag Adr Stock (FMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):